Open Access

Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma

  • Authors:
    • Changfu Liu
    • Zhou Tong
    • Jingyu Tan
    • Zengxi Xin
  • View Affiliations

  • Published online on: July 26, 2019     https://doi.org/10.3892/etm.2019.7814
  • Pages: 2187-2193
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to analyze the percentage of regulatory T cells (Treg) and T helper cell 17 (Th17) cells in the peripheral blood of patients with tongue squamous cell carcinoma (TSCC) to provide novel insight into the development of immune‑targeting therapies for TSCC. Peripheral blood samples were collected from 40 patients with TSCC then the peripheral blood mononuclear cells (PBMCs) and plasma were isolated for flow cytometry, cytometric bead array and reverse transcription‑quantitative PCR. Results demonstrated that the percentage of cluster of differentiation (CD)4+ T cells in the peripheral blood of patients with TSCC decreased significantly compared with the control. However, the percentage of Treg and Th17 cells increased significantly compared with the control. The levels of interleukin (IL)‑10 and IL‑17a increased significantly in patients with TSCC. Expression of IL‑10 and IL‑17 in the advanced stages of cancer (stage III or IV) were significantly higher compared with the early stages (I and II). The mRNA expression levels of the transcription factors forkhead box protein 3 and RAR‑related orphan receptor‑γ increased significantly with stage of cancer. The percentage of Treg cells and Th17 cells increased significantly in patients with TSCC suggesting that there was an imbalance between Treg and Th17 cells. In conclusion, altered Treg/Th17 balance in TSCC may promote the disease progression and these results provide a theoretical basis for the development of immunomodulators targeting Treg/Th17.

References

1 

Yu X and Li Z: MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma. J Cell Mol Med. 20:10–16. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Finotello F and Eduati F: Multi-omics profiling of the tumor microenvironment: paving the way to precision immuno-oncology. Front Oncol. 8:4302018. View Article : Google Scholar : PubMed/NCBI

3 

Kim J and Bae JS: Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI

4 

Jiang W, Chan CK, Weissman IL, Kim BYS and Hahn SM: Immune priming of the tumor microenvironment by radiation. Trends Cancer. 2:638–645. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Sahoo SS, Zhang XD, Hondermarck H and Tanwar PS: The emerging role of the microenvironment in endometrial cancer. Cancers (Basel). 10(pii): E4082018. View Article : Google Scholar : PubMed/NCBI

6 

Steven A and Seliger B: The role of immune escape and immune cell infiltration in breast cancer. Breast Care (Basel). 13:16–21. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP and Chouaib S: New insights into the role of EMT in tumor immune escape. Mol Oncol. 11:824–846. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Spranger S: Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. Int Immunol. 28:383–391. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Barbi J, Pardoll D and Pan F: Treg functional stability and its responsiveness to the microenvironment. Immunol Rev. 259:115–139. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Guéry L and Hugues S: Th17 Cell plasticity and functions in cancer immunity. Biomed Res Int. 2015:3146202015. View Article : Google Scholar : PubMed/NCBI

11 

Zhou X, Su YX, Lao XM, Liang YJ and Liao GQ: CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol. 53:27–35. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Sobin LH, Gospodarowicz MK and Wittekind CH: UICC International Union Against Cancer TNM Classification of Malignant Tumors. 7th. West Sussex, United Kingdom: Wiley-Blackwell; 2009

14 

Zamarron BF and Chen W: Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Jadidi-Niaragh F, Ghalamfarsa G, Memarian A, Asgarian-Omran H, Razavi SM, Sarrafnejad A and Shokri F: Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia. Tumour Biol. 34:929–940. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Duan MC, Han W, Jin PW, Wei YP, Wei Q, Zhang LM and Li JC: Disturbed Th17/treg balance in patients with non-small cell lung cancer. Inflammation. 38:2156–2165. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Chaudhary B and Elkord E: Regulatory T cells in the tumor microenvironment and cancer progression: Role and therapeutic targeting. Vaccines (Basel). 4(pii): E282016. View Article : Google Scholar : PubMed/NCBI

18 

Tanaka A and Sakaguchi S: Regulatory T cells in cancer immunotherapy. Cell Res. 27:109–118. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Elkord E, Alcantar-Orozco EM, Dovedi SJ, Tran DQ, Hawkins RE and Gilham DE: T regulatory cells in cancer: Recent advances and therapeutic potential. Expert Opin Biol Ther. 10:1573–1586. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Rasku MA, Clem AL, Telang S, Taft B, Gettings K, Gragg H, Cramer D, Lear SC, McMasters KM, Miller DM and Chesney J: Transient T cell depletion causes regression of melanoma metastases. J Transl Med. 6:122008. View Article : Google Scholar : PubMed/NCBI

21 

Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P and Ghiringhelli F: Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res. 14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Liang YJ, Lao XM, Liang LZ and Liao GQ: Genome-wide analysis of cancer cell-derived Foxp3 target genes in human tongue squamous cell carcinoma cells. Int J Oncol. 46:1935–1943. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Li K, Huang SH, Lao XM, Yang L, Liao GQ and Liang YJ: Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma. Exp Cell Res. 370:643–652. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Zhu S and Qian Y: IL-17/IL-17 receptor system in autoimmune disease: Mechanisms and therapeutic potential. Clin Sci (Lond). 122:487–511. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Chen X and Oppenheim JJ: Th17 cells and Tregs: Unlikely allies. J Leukoc Biol. 95:723–731. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D and Yu H: IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 206:1457–1464. 2009. View Article : Google Scholar : PubMed/NCBI

27 

De Simone V, Franzè E, Ronchetti G, Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 34:3493–3503. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Yang F, Wang D, Li Y, Sang L, Zhu J, Wang J, Wei B, Lu C and Sun X: Th1/Th2 balance and Th17/treg-mediated immunity in relation to murine resistance to dextran sulfate-induced colitis. J Immunol Res. 2017:70472012017. View Article : Google Scholar : PubMed/NCBI

29 

Sun J, Li L, Li L, Ding L, Liu X, Chen X, Zhang J, Qi X, Du J and Huang Z: Metallothionein-1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance. Eur J Immunol. 48:1550–1562. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Zhao L, Yang J, Wang HP and Liu RY: Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma. Med Oncol. 30:4612013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, C., Tong, Z., Tan, J., & Xin, Z. (2019). Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma. Experimental and Therapeutic Medicine, 18, 2187-2193. https://doi.org/10.3892/etm.2019.7814
MLA
Liu, C., Tong, Z., Tan, J., Xin, Z."Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma". Experimental and Therapeutic Medicine 18.3 (2019): 2187-2193.
Chicago
Liu, C., Tong, Z., Tan, J., Xin, Z."Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma". Experimental and Therapeutic Medicine 18, no. 3 (2019): 2187-2193. https://doi.org/10.3892/etm.2019.7814